Navigation Links
Peptide Machines, Inc. Introduces New High-Quality, Cost-Efficient, Fully Automated Multiple Peptide Synthesizer with Preactivation
Date:8/23/2013

San Diego, CA (PRWEB) August 23, 2013

Discovery-4 is a 4-vessel peptide synthesizer designed to overcome the shortcomings and unnecessary complexity of existing synthesizers. The unique design prevents any precipitation, clogged lines, and overfills so typical of other instruments. The use of stock solutions of AA's eliminates the need for pre-fill cartridges or barcoding. The Discovery-4 has a preactivation vessel for every reaction vessel, which allows the synthesis of excellent quality peptides with a single coupling protocol.

The instrument's inherent flexibility for reagent set-up makes Discovery-4 very effective for both small and large scale synthesis from 0.05 mmol to 3 mmol. The system's precise metering pump delivery, patented solvent measuring device, and drastic washes reduction, cuts reagent and solvent consumption in half, thus reducing cost and minimizing waste. Discovery-4 utilizes 30, 60 and 100 ml glass reactors with removable filters. Each reactor can run independently with different scales and protocols.

The easy to use powerful software allows the user to effortlessly import sequences from USB, assign protocols to sequences, and sequences to reaction vessels. The calculation table, which is generated, provides the quantity of reagents required, allowing the user to very quickly go from an idea to execution.

The small footprint and fully ventilated hood make Discovery-4 suitable for any size peptide lab. With all this and more, the Discovery-4 is an ideal tool for R&D, process optimization, and peptide production.

For more information please visit http://www.peptidemachines.com/.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11051115.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Oncopeptides Initiates Phase II Clinical Study with Melflufen in the Treatment of Multiple Myeloma Patients
2. Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics
3. CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis
4. New Book Chapter from CEM on Microwave Peptide Synthesis
5. Atlantic Peptides Teams Up with a United Kingdom Company to Offer cGMP Peptides and API
6. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
7. Aurigene Highlights its PD-1 peptide, Bet Bromodomain and NAMPT Inhibitors Program at AACR 2013
8. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
9. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
10. Small peptide ameliorates autoimmune skin blistering disease in mice
11. US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 /PRNewswire/ - FACIT announced a seed stage ... a start-up created by FACIT focused on developing ... combined with non-dilutive capital, achieves a targeted $3.0M ... enables Propellon to accelerate the nomination of a ... and/or entering a strategic partnership for clinical trials ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... acquire information on the desired increase and/or decrease in antibody-dependent cellular cytotoxicity or ... N-glycosylation profiling of therapeutic antibodies. , To meet this demand, the team ...
(Date:3/22/2017)... , ... March 21, 2017 , ... Functional near-infrared spectroscopy ... is being explored as a way to track the brain’s response to acute pain ... activation by cold pressor test ,” published today in the journal Neurophotonics , ...
(Date:3/22/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced Alexey Eliseev ... at the 5th Annual Cancer BioPartnering & Investment ... present to and meet with thought leaders from ... as well as institutional investors. This event will ...
Breaking Biology Technology:
(Date:3/16/2017)... 2017 CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity ... Used combined in one project, multi-biometric ... ...
(Date:3/7/2017)... 7, 2017   HireVue , the leading provider ... identify the best talent, faster, today announced the additions ... (CSO) and Diana Kucer as Chief Marketing ... executive team poised to drive continued growth in the ... year of record bookings in 2017. "Companies ...
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
Breaking Biology News(10 mins):